These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35678039)

  • 1. Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.
    Burra P; Russo FP
    Liver Int; 2022 Jun; 42(6):1225-1228. PubMed ID: 35678039
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
    Wijtvliet V; Wissing KM; Abramowicz D; Ledeganck KJ
    J Am Soc Nephrol; 2022 Apr; 33(4):869-870. PubMed ID: 35165123
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
    Meunier L; Sanavio M; Dumortier J; Meszaros M; Faure S; Ursic Bedoya J; Echenne M; Boillot O; Debourdeau A; Pageaux GP
    Liver Int; 2022 Aug; 42(8):1872-1878. PubMed ID: 35338550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
    Dumortier J
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101743. PubMed ID: 34146727
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for.
    Thompson MA; Martinez-Barbini F; Mendizabal M
    Ann Hepatol; 2023; 28(3):101081. PubMed ID: 36882137
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination against SARS-CoV-2 in liver transplant recipients: The game is still long and the outcome is uncertain.
    Toniutto P; Cussigh A; Cmet S; Falleti E
    Liver Int; 2022 Oct; 42(10):2341. PubMed ID: 35906808
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.
    Matsunami M; Suzuki T; Yashima J; Kuji H; Matsue K
    Clin Exp Nephrol; 2023 Jan; 27(1):98-99. PubMed ID: 35931918
    [No Abstract]   [Full Text] [Related]  

  • 8. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients.
    Guarino M; Esposito I; Portella G; Cossiga V; Loperto I; Tortora R; Cennamo M; Capasso M; Terracciano D; Galeota Lanza A; Di Somma S; Picciotto FP; Morisco F;
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1534-1541.e4. PubMed ID: 35066136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
    McEvoy CM; Lee A; Misra PS; Lebovic G; Wald R; Yuen DA
    Transplantation; 2022 May; 106(5):e279-e280. PubMed ID: 35220385
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
    Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
    Front Immunol; 2022; 13():906225. PubMed ID: 35720376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients.
    Gavriilaki E; Papadopoulou A; Touloumenidou T; Stavridou F; Koravou EE; Giannaki M; Papalexandri A; Karavalakis G; Batsis I; Kourelis A; Chatzopoulou F; Chatzidimitriou D; Sotiropoulos D; Yannaki E; Sakellari I; Anagnostopoulos A
    Bone Marrow Transplant; 2022 Jul; 57(7):1183-1186. PubMed ID: 35449455
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients.
    Odriozola A; Lamadrid-Perojo P; Cuadrado A; San Segundo D; Del Barrio M; Fortea JI; Puente A; Amigo L; Fernández-Santiago R; Castillo F; Achalandabaso M; Andrés Echeverri J; Rodríguez-Sanjuan JC; López-Hoyos M; Crespo J; Fábrega E
    Transplantation; 2022 Jul; 106(7):e341-e342. PubMed ID: 35323163
    [No Abstract]   [Full Text] [Related]  

  • 14. Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
    Reuken PA; Albers S; Rauchfuss F; Strnad P; Settmacher U; Trautwein C; Stallmach A; Bruns T
    Z Gastroenterol; 2021 Dec; 59(12):1288-1296. PubMed ID: 34670294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events after SARS-CoV-2 vaccination in solid organ transplant recipients: A systematic review.
    Villavicencio A; Ebisu Y; Raja M; Sanchez-Covarrubias AP; Reynolds JM; Natori Y
    Transpl Infect Dis; 2022 Dec; 24(6):e13936. PubMed ID: 36067062
    [No Abstract]   [Full Text] [Related]  

  • 17. High acceptance rate of COVID-19 vaccination in liver transplant recipients.
    Giannini EG; Marenco S
    J Hepatol; 2021 Aug; 75(2):483-484. PubMed ID: 34052253
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients.
    Mitchell J; Chiang TP; Alejo JL; Chang A; Abedon AT; Avery RK; Tobian AAR; Massie AB; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 May; 106(5):e269-e270. PubMed ID: 35250006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.